Heterosofir 400 mg F.C.T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Heterosofir 400 mg F.C.T, covering 2015-07-08 to 2015-07-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland) [Phase 1]